Ischemia Global Clinical Trials Review, H1, 2013

  • June 2013
  • -
  • Global Data
  • -
  • 112 pages

Ischemia Global Clinical Trials Review, H1, 2013



Summary



GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, H1, 2013" provides data on the Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Ischemia 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Ischemia 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Ischemia Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AnGes MG, Inc. 35
Clinical Trial Overview of AnGes MG, Inc. 35
Sanofi 36
Clinical Trial Overview of Sanofi 36
Lacer, S.A. 37
Clinical Trial Overview of Lacer, S.A. 37
Sangart, Inc. 38
Clinical Trial Overview of Sangart, Inc. 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
TCA Cellular Therapy, LLC 40
Clinical Trial Overview of TCA Cellular Therapy, LLC 40
Stempeutics Research Private Limited 41
Clinical Trial Overview of Stempeutics Research Private Limited 41
Medicure Inc. 42
Clinical Trial Overview of Medicure Inc. 42
ReNeuron Group plc 43
Clinical Trial Overview of ReNeuron Group plc 43
Pluristem Therapeutics Inc. 44
Clinical Trial Overview of Pluristem Therapeutics Inc. 44
Medistem, Inc. 45
Clinical Trial Overview of Medistem, Inc. 45
ViroMed Co., Ltd. 46
Clinical Trial Overview of ViroMed Co., Ltd. 46
United Therapeutics Corporation 47
Clinical Trial Overview of United Therapeutics Corporation 47
Cytori Therapeutics, Inc. 48
Clinical Trial Overview of Cytori Therapeutics, Inc. 48
Merck and Co., Inc. 49
Clinical Trial Overview of Merck and Co., Inc. 49
medac GmbH 50
Clinical Trial Overview of medac GmbH 50
Gilead Sciences, Inc. 51
Clinical Trial Overview of Gilead Sciences, Inc. 51
AstraZeneca PLC 52
Clinical Trial Overview of AstraZeneca PLC 52
Forest Laboratories, Inc. 53
Clinical Trial Overview of Forest Laboratories, Inc. 53
Mitsubishi Tanabe Pharma Corporation 54
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 54
Clinical Trial Overview of Top Institutes / Government 55
National Heart, Lung, and Blood Institute 55
Clinical Trial Overview of National Heart, Lung, and Blood Institute 55
Radboud University 59
Clinical Trial Overview of Radboud University 59
Northwestern University 60
Clinical Trial Overview of Northwestern University 60
Medical University of Vienna 61
Clinical Trial Overview of Medical University of Vienna 61
Leiden University Medical Center 62
Clinical Trial Overview of Leiden University Medical Center 62
University Hospital Freiburg 63
Clinical Trial Overview of University Hospital Freiburg 63
Imperial College London 64
Clinical Trial Overview of Imperial College London 64
Duke University 65
Clinical Trial Overview of Duke University 65
U.S. Department of Veterans Affairs 66
Clinical Trial Overview of U.S. Department of Veterans Affairs 66
Seoul National University Hospital 67
Clinical Trial Overview of Seoul National University Hospital 67
Asan Medical Center 68
Clinical Trial Overview of Asan Medical Center 68
Yale University 69
Clinical Trial Overview of Yale University 69
Erasmus MC 70
Clinical Trial Overview of Erasmus MC 70
Charite - Universitatsmedizin Berlin 71
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 71
Kyushu University 72
Clinical Trial Overview of Kyushu University 72
Academic Medical Centre 73
Clinical Trial Overview of Academic Medical Centre 73
Fundacion Progreso y Salud 74
Clinical Trial Overview of Fundacion Progreso y Salud 74
Maastricht University Medical Center 75
Clinical Trial Overview of Maastricht University Medical Center 75
Assistance Publique - Hopitaux de Paris 76
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 76
University of Florida 77
Clinical Trial Overview of University of Florida 77
Five Key Clinical Profiles 78
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112

List of Tables

Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 15
Ischemia Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Ischemia Therapeutics Clinical Trials, G7 Countries, 2013* 17
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Ischemia Therapeutics Clinical Trials, E7 Countries, 2013* 19
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Ischemia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Ischemia Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Ischemia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Ischemia Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2013* 35
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 36
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lacer, S.A., 2013* 37
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sangart, Inc., 2013* 38
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 39
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular Therapy, LLC, 2013* 40
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stempeutics Research Private Limited, 2013* 41
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2013* 42
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2013* 43
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2013* 44
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medistem, Inc., 2013* 45
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2013* 46
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2013* 47
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2013* 48
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2013* 49
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2013* 50
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013* 51
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 52
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 53
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2013* 54
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 55
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 59
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2013* 60
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 61
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 62
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2013* 63
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013* 64
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 65
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 66
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2013* 67
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2013* 68
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013* 69
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2013* 70
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2013* 71
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2013* 72
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 73
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Progreso y Salud, 2013* 74
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2013* 75
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 76
Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2013* 77

List of Figures

Ischemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 15
Ischemia Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Ischemia Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Ischemia Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Ischemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
GlobalData Methodology 110

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1686 biological ...

Biologicals in Oncology: Drug Pathway Analyzer 2014

Biologicals in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1421 biological drugs known to affect more than 266 specific intracellular signaling pathways for the treatment ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.